Quintrio
Home

Stock overview

Aurora Cannabis Inc. Common Shares

ACB

Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.

Last trade $4.54
Day change -$0.07 (-1.52%)
Day range $4.53 – $4.63
Volume 589,938
Market cap $303M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for ACB.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for ACB.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
The Motley Fool

Why Didn't Tilray Brands Make a Bid for Aurora Cannabis?

Tilray Brands has not made a bid for Aurora Cannabis despite being an acquisition-hungry company, as its strategic focus has shifted toward U.S. beverage acquisitions and craft brewing rather than expanding in the competitive Canadian cannabis market. The company recently announced consolidation efforts in Canada to focus on profitability, making a major acquisition of a Canadian producer like Aurora less attractive to its long-term strategy.

The Motley Fool

The Big Winner From the Aurora Cannabis-Organigram Deal: Curaleaf

Organigram agreed to acquire Aurora Cannabis at a 21% premium over Curaleaf's hostile takeover offer. However, the article argues that Curaleaf emerges as the real winner because the combined Organigram-Aurora entity will be more entrenched in the declining Canadian recreational cannabis market. Curaleaf, with stronger financials and U.S. operations, may eventually acquire the combined company at a lower valuation if the deal underperforms.

The Motley Fool

Which of These 5 Cannabis Stocks Has the Strongest Balance Sheet?

An analysis of five major cannabis stocks reveals significant differences in financial health. Cronos Group leads with approximately $841 million in cash and no significant debt, followed closely by SNDL, which is debt-free with positive free cash flow. Tilray and Canopy Growth continue to struggle with debt and negative cash flow despite some revenue growth, while Aurora Cannabis has a smaller liquidity cushion. A strong balance sheet provides financial flexibility but doesn't guarantee profitability or shareholder returns.

Zacks Investment Research

Post-Q3 Earnings: Is SNDL Stock a Portfolio Must-Have?

SNDL Inc. reported mixed Q3 2026 results with revenues beating estimates at $170.1 million but adjusted loss per share wider than expected. The company is intensifying shareholder returns through 5.4 million share repurchases and exploring a C$50 million issuer bid. SNDL increased its Parallel ownership to 92% to expand U.S. medical cannabis exposure, though margin pressure and weak cannabis sales persist, with management implementing cost-reduction measures.

Zacks Investment Research

ACB's Q2 Earnings on Deck: International Medical Cannabis in Focus

Aurora Cannabis is expected to report Q2 fiscal 2027 revenues of $52.5 million, down 20.1% year-over-year, due to strategic exits from lower-margin Canadian markets and a 30% cut in Canadian reimbursement rates. However, the company is seeing growth support from strong German demand and expansion opportunities in Poland and Australia through its Safari Flower Company acquisition.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

Ex-dividendAmount / sharePay dateType
Dec 19, 2007$1.05Dec 31, 2007unknown
Dec 19, 2007$3.78Dec 31, 2007unknown
Dec 19, 2007$18.7392Dec 31, 2007unknown

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Feb 20, 20241-for-10reverse split
May 11, 20201-for-12reverse split